• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Nuance Announces Acquisition of Saykara

Share:

February 16, 2021

Nuance Communications, Inc. (NASDAQ: NUAN) today announced the acquisition of Saykara, Inc., a like-minded startup focused on developing a mobile AI assistant to automate clinical documentation for physicians. The acquisition underscores Nuance’s ongoing expansion of market and technical leadership in conversational artificial intelligence (AI) and ambient clinical intelligence (ACI) solutions that reduce clinician burnout, enhance patient experiences, and improve overall health system financial integrity.

“The complementary technology built by the Saykara team aligns strongly with our technology portfolio and growth strategy as well as the needs of our clients,” said Joe Petro, Nuance Executive Vice President and Chief Technology Officer. “This acquisition welcomes some familiar and highly respected technology leaders whom I am excited to have join our research and development team, which consists of the best and brightest minds in applying AI and machine learning to healthcare. With a shared vision, we will continue our aggressive focus on innovation, growth, and on delivering industry-leading AI-powered solutions that meaningfully address the compelling business problems that our healthcare clients and their clinicians face every day.”

Saykara was founded in Seattle in 2015 by Harjinder Sandhu, PhD, a serial entrepreneur who previously served as an executive in Nuance’s R&D division. Sandhu and Saykara’s team of leading engineers, machine learning experts, and experienced technology executives will join Nuance’s research and development team.

“I welcome the opportunity to rejoin the market leader in conversational AI and ambient clinical intelligence, and the impressive Nuance research and development team – especially at this important juncture in the development and adoption of these AI-powered healthcare innovations,” said Saykara Founder and CEO Harjinder Sandhu. “We are very familiar with Nuance’s advanced technology, domain expertise, and world-class technical team and share the company’s mission to make what matters to alleviate the clinical documentation burden on clinicians around the world.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sansoro Health and Datica Announce MergerSansoro Health and Datica Announce Merger
  • LevelJump Healthcare Corp. Announces the Acquisition of Four Diagnostic Imaging ClinicsLevelJump Healthcare Corp. Announces the Acquisition of Four Diagnostic Imaging Clinics
  • Global Antipsychotic Drugs Market to Reach US$ 20,539.5 Mn by 2026Global Antipsychotic Drugs Market to Reach US$ 20,539.5 Mn by 2026
  • Foundation Health | Revolutionizing Healthcare Experiences with InnovationFoundation Health | Revolutionizing Healthcare Experiences with Innovation
  • GENFIT Announces Signature of the Share Purchase Agreement and the Completion of Its Acquisition of VersantisGENFIT Announces Signature of the Share Purchase Agreement and the Completion of Its Acquisition of Versantis
  • L2 Capital Partners Supports Jurassic Quest, a Rapidly Growing Family Event PlatformL2 Capital Partners Supports Jurassic Quest, a Rapidly Growing Family Event Platform
  • Biotech PTC to acquire Lynnfield’s Agilis in $200M dealBiotech PTC to acquire Lynnfield’s Agilis in $200M deal
  • Exclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca PlcExclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca Plc

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications